Literature DB >> 30249471

Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.

Daniel Kamp1, Christina Engelke2, Thomas Wobrock3, Wolfgang Wölwer4, Georg Winterer5, Christian Schmidt-Kraepelin6, Wolfgang Gaebel7, Berthold Langguth8, Michael Landgrebe9, Peter Eichhammer10, Elmar Frank11, Göran Hajak12, Christian Ohmann13, Pablo E Verde14, Marcella Rietschel15, Ahmed Raees16, William G Honer17, Berend Malchow18, Thomas Schneider-Axmann19, Peter Falkai20, Alkomiet Hasan21, Joachim Cordes22.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30249471     DOI： 10.1016/j.schres.2018.09.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up Study.

Authors:  Mei Hong Xiu; Heng Yong Guan; Jian Min Zhao; Ke Qiang Wang; Yan Fen Pan; Xiu Ru Su; Yu Hong Wang; Jin Ming Guo; Long Jiang; Hong Yu Liu; Shi Guang Sun; Hao Ran Wu; Han Song Geng; Xiao Wen Liu; Hui Jing Yu; Bao Chun Wei; Xi Po Li; Tammy Trinh; Shu Ping Tan; Xiang Yang Zhang
Journal:  Schizophr Bull       Date:  2020-03-17       Impact factor: 9.306

2.  Transcranial Direct Current Stimulation Over Prefrontal Areas Improves Psychomotor Inhibition State in Patients With Traumatic Brain Injury: A Pilot Study.

Authors:  Xu Zhang; Baohu Liu; Nan Li; Yuanyuan Li; Jun Hou; Guoping Duan; Dongyu Wu
Journal:  Front Neurosci       Date:  2020-05-20       Impact factor: 4.677

3.  The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response.

Authors:  Chuan-Chia Chang; Yu-Chen Kao; Che-Yi Chao; Nian-Sheng Tzeng; Hsin-An Chang
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.